Stock screenerAll disclosures →
EDGAR →
OGEN
Conviction 0HealthcareScan · Mon, Aug 10, 2026OGEN$0.5440-1.07%
ResistanceSupportVol 14Vol MA14 22.72K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price0.5440
Change-1.07%
Gap-3.00%
Rel volume0.26×
Avg volume22.93K
Avg $ vol12.16K
SMA 200.5301
SMA 500.5682
SMA 2000.7524
Price vs 50-4.26%
Price vs 200-27.69%
MA stackbearish
50/200 cross—
Supertrenddown · 0.5860
RSI (14)50
MACD hist0.01
MACD crossbull · 4d
Stoch %K / %D59 / 61
ADX (14)22
+DI / −DI17 / 17
RSI divergence—
MACD divergence—
ATR %+5.42%
ADR %5.88%
52w high1.42
52w low0.4902
From 52w high-61.69%
Above 52w low+10.98%
New 52w highNo
SqueezeOff
Bollinger width17.97%
%B0.65
Donchian pos55.04%
Donchian high0.5962
Donchian low0.4801
AVWAP (52w high)0.8822
vs AVWAP high-38.33%
AVWAP (52w low)0.5218
vs AVWAP low+4.26%
OBV trendDown
Chaikin MF (20)-0.10
Today vs 20d0.26×
Avg vol (14d)22.72K
Avg vol (20d)22.93K
Avg $ vol (20d)12.16K
Market cap2.45M
RS 3m (vs SPY)-15.99%
RS 6m (vs SPY)-29.48%
RS line new highNo
Trend template0/8
Technical rank18.8
1 week+2.78%
1 month-7.18%
3 months-8.88%
6 months-25.68%
1 year-58.15%
YTD-34.85%
P/E-0.25
P/B0.40
P/S65.19
P/FCF-0.26
EPS-4.56
Div yield—
ROE-159.22%
ROA-131.41%
Debt/Eq—
Current4.17
EV/EBITDA0.39
Gross margin0.00%
Net margin—
Rev growth0.00%
EPS growth6.86%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value-3.65M
Revenue7.47K
Net income-2.2M
Gross profit0
Free cash flow-9.37M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNYSE
Shares out4.51M
Employees3
ListedThu, Jul 3, 2003
Free float3.3M
Float %76.2%
Short interest783.09K
Days to cover28.7d
Short volume21.4%
Squeeze score65 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank18.8 / 100
Group rank—
Status laneNo active setup
Setup direction—
Pattern family
Resistance0.6031
Support0.4876
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in OGEN
No recent disclosed trades by Congress in OGEN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in OGEN · 1 buy
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Spencer John Chief Financial Officer · Employee Stock Option (right to buy) · 2026-07-01 | Grant | 55.9K | — | 2026-07-01 | 2026-07-07 |
SEC filings
EDGAR filings in OGEN · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.